Tyme Technologies, Inc. (NASDAQ:TYME – Get Rating) major shareholder Michael Demurjian sold 53,097 shares of the company’s stock in a transaction on Tuesday, May 31st. The stock was sold at an average price of $0.25, for a total value of $13,274.25. Following the completion of the sale, the insider now owns 23,355,749 shares of the […]
Form NPORT-P FIRST TRUST EXCHANGE-TRA For: Mar 31 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
25.05.2022 - - $84.0 million in cash and marketable securities as of March 31, 2022 -BEDMINSTER, N.J., May 25, 2022 (GLOBE NEWSWIRE) - TYME Technologies, Inc. (Nasdaq: TYME) (the Company or TYME), an emerging biotechnology company developing cancer .
Tyme Technologies, Inc. (NASDAQ:TYME – Get Rating) major shareholder Michael Demurjian sold 40,000 shares of the company’s stock in a transaction that occurred on Tuesday, April 19th. The shares were sold at an average price of $0.32, for a total value of $12,800.00. Following the completion of the transaction, the insider now directly owns 23,648,846 […]